Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The tumor ablation therapy devices market has experienced substantial growth recently, driven by advancements in cancer treatment and increasing demand for less invasive options. As cancer rates rise globally, the need for effective and targeted therapies is pushing this market forward. Let’s explore the current market size, the factors fueling its expansion, key segments, industry trends, prominent companies, and regional insights shaping its future.
Steady Expansion in the Tumor Ablation Therapy Devices Market Size
The tumor ablation therapy devices market is forecasted to grow significantly over the coming years. It is projected to increase from $0.82 billion in 2025 to $0.95 billion in 2026, representing a strong compound annual growth rate (CAGR) of 15.0%. This growth in the recent past is largely attributable to rising cancer incidence, the establishment of more oncology treatment centers, wider adoption of minimally invasive therapies, improvements in imaging technologies, and a growing preference for treatments that preserve organ function.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
Looking ahead, the market is expected to expand further and reach $1.61 billion by 2030, with a CAGR of 14.2%. Key drivers during this period include increased investments in precision oncology, higher demand for outpatient cancer treatments, continuous development of advanced ablation technologies, enhanced integration of imaging with therapy systems, and a stronger focus on personalized cancer care. Upcoming trends include the rising use of image-guided ablation systems, greater adoption of minimally invasive tumor ablation procedures, expansion of percutaneous treatment techniques, and the growing popularity of organ-specific ablation technologies.
The Rising Impact of Cancer Prevalence on Market Growth
A major force propelling the tumor ablation therapy devices market is the increasing prevalence of cancer worldwide. Cancer ranks as the second leading cause of death, with about one in six deaths globally attributed to the disease. The growing number of cancer cases is closely linked to aging populations, as older adults face a higher lifetime risk of developing various cancers. Tumor ablation procedures are commonly used to treat tumors in organs like the lung, liver, kidney, and bones due to their minimally invasive nature.
Access The Complete Tumor Ablation Therapy Devices Market Report:
For example, in 2023, the American Cancer Society projected that 1,958,310 new cancer cases would be diagnosed in the United States, marking an increase from 1,918,030 cases in 2022. Since tumor ablation is an effective option for patients who have not responded well to chemotherapy or radiotherapy, this supports steady demand for ablation devices and fuels market growth.
Detailed Segmentation of the Tumor Ablation Therapy Devices Market
This market is categorized by technology, treatment type, application, and end user to better understand growth opportunities. Technologies include Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, and others. Treatment types are divided into surgical, laparoscopic, and percutaneous methods. Applications span various cancers such as kidney, liver, breast, lung, prostate, and others. End users range from hospitals to oncology clinics and other facilities.
Further subsegments include monopolar and bipolar devices for Radiofrequency Ablation; high- and low-frequency options for Microwave Ablation; liquid nitrogen and argon gas devices under Cryoablation; NanoKnife systems and high-voltage pulse generators for Irreversible Electroporation; and additional technologies like laser ablation, ultrasound-guided high-intensity focused ultrasound (HIFU), and chemical ablation techniques.
Innovations and Industry Shifts Reshaping Demand in Tumor Ablation Devices
Leading companies in this sector are concentrating on developing minimally invasive therapies that provide precise tumor targeting while minimizing damage to surrounding tissues. Such advancements help maintain treatment effectiveness while reducing complications and recovery time.
For instance, in August 2023, Francis Medical Inc., a US-based provider specializing in minimally invasive cancer treatments, received Breakthrough Device Designation from the FDA for its Vanquish water vapor ablation therapy targeting prostate cancer. This designation aims to accelerate the device’s development and regulatory review, potentially allowing faster patient access. The Vanquish system delivers thermal energy through sterile water via a simple transurethral procedure, destroying cancer cells while protecting nearby tissues and lowering the risk of side effects commonly seen with other prostate cancer treatments.
Prominent Players Leading the Tumor Ablation Therapy Devices Market
Several key companies hold significant positions in this market, including Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., and Bovie Medical Corporation.
Regions Driving Revenue and Market Leadership in Tumor Ablation Therapy Devices
In 2025, North America emerged as the largest regional market for tumor ablation therapy devices, benefiting from a well-established healthcare infrastructure and high adoption of advanced technologies. Asia-Pacific ranked as the second-largest market, showing promising growth potential due to increasing healthcare investments and rising cancer incidence. The market outlook also covers other areas such as South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, offering a comprehensive global perspective.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model